StockNews.com Begins Coverage on Retractable Technologies (NYSE:RVP)

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research report report published on Sunday. The firm issued a hold rating on the stock.

Retractable Technologies Price Performance

Retractable Technologies stock opened at $0.92 on Friday. The company has a market cap of $27.47 million, a price-to-earnings ratio of -3.53 and a beta of 2.11. The firm’s fifty day moving average is $1.10 and its 200 day moving average is $1.14. The company has a quick ratio of 8.18, a current ratio of 11.02 and a debt-to-equity ratio of 0.01. Retractable Technologies has a 52-week low of $0.87 and a 52-week high of $1.34.

Retractable Technologies (NYSE:RVP) last released its quarterly earnings results on Wednesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The company had revenue of $7.60 million for the quarter. Retractable Technologies had a negative net margin of 18.84% and a negative return on equity of 7.55%.

Insider Activity at Retractable Technologies

In related news, CEO Thomas J. Shaw purchased 48,635 shares of Retractable Technologies stock in a transaction that occurred on Thursday, May 16th. The shares were bought at an average price of $1.03 per share, with a total value of $50,094.05. Following the purchase, the chief executive officer now directly owns 14,417,148 shares of the company’s stock, valued at approximately $14,849,662.44. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have acquired a total of 129,367 shares of company stock valued at $135,644 over the last 90 days. 54.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Retractable Technologies stock. WealthTrust Axiom LLC increased its stake in Retractable Technologies, Inc. (NYSE:RVP) by 27.8% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 126,533 shares of the company’s stock after purchasing an additional 27,500 shares during the period. WealthTrust Axiom LLC owned 0.42% of Retractable Technologies worth $151,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.